Pfizer, Inc.

PFE

US7170811035

Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines (52.4%); - drugs for the treatment of cancer (15.2%); - cardiovascular, metabolic and analgesic drugs (11.5%); - injectable, anti-infectives drugs and active pharmaceutical ingredients (9%); - drugs for inflammatory and immune diseases (5.5%); - drugs for rare diseases (4.4%); - other (2%). At the end of 2021, the group had more than 39 production sites worldwide. Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).

Sector

Pharmaceuticals

Calendar

2023-12-09 - American Society of Hematology Meeting - Abstract Number -14

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT

More Strategies

Ratings for Pfizer, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

28.91USD

Average target price

40.46USD

Spread / Average Target

+39.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PFIZER, INC.	-43.58%	163 B $
ELI LILLY AND COMPANY	+59.64%	525 B $
NOVO NORDISK A/S	+48.98%	454 B $
JOHNSON & JOHNSON	-10.34%	381 B $
ABBVIE INC.	-11.26%	253 B $
ROCHE HOLDING AG	-17.52%	221 B $
NOVARTIS AG	+2.14%	202 B $
ASTRAZENECA PLC	-9.09%	200 B $
AMGEN INC.	+3.74%	146 B $
SANOFI	-4.52%	117 B $

Other Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:16 2023-12-01 pm EST			5-day change	1st Jan Change
28.91 ^USD	-5.12%		-5.21%	-43.58%

Dec. 02	Health Up as Pfizer Slides -- Health Care Roundup	DJ
Dec. 02	S&P 500 hits highest 2023 close on rate cut hopes	RE

Health Up as Pfizer Slides -- Health Care Roundup	Dec. 01	DJ
S&P 500 hits highest 2023 close on rate cut hopes	Dec. 01	RE
Equity Markets Rise as Investors Weigh Fed Chair Remarks	Dec. 01	MT
Equity Markets Rise as Investors Weigh Fed Chair Remarks	Dec. 01	MT
US Equity Markets Close Higher Friday Following Powell's Comments on Rate Policy	Dec. 01	MT
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	Dec. 01	MT
Wall St rallies as Powell cements peak rate bets	Dec. 01	RE
Sector Update: Health Care Stocks Rise in Afternoon Trading	Dec. 01	MT
Equity Markets Rise Intraday as Traders Weigh Fed Chair Remarks	Dec. 01	MT
Sector Update: Health Care	Dec. 01	MT
Powell's Restrictive Stand on Rate Hikes Pushes Equities Slightly Higher Friday Afternoon	Dec. 01	MT
Powell's Comments on Interest-Rate Hikes Leave Equities Modestly Higher Friday Afternoon	Dec. 01	MT
Wall St edges higher as Powell comments bolster peak-rate bets	Dec. 01	RE
Top Stories at Midday: Tesla's Cybertruck Hits the Road; Pfizer Pivots Danuglipron Development; Ulta Beats; Gaza Truce Ends; Powell Remains Restrictive	Dec. 01	MT
Pfizer Halts Development of Twice-Daily Weight Loss Drug	Dec. 01	MT
PFIZER INC : UBS sticks Neutral	Dec. 01	ZD
Global markets live: Meta, Tesla, BP Plc, Pfizer, General Motors...	Dec. 01
Trending : Pfizer Obesity Drug Shows Mixed Study Results; Trial Discontinued	Dec. 01	DJ
PFIZER INC : JP Morgan remains Neutral	Dec. 01	ZD
Dpa-AFX Overview: COMPANIES from 01.12.2023 - 15:15	Dec. 01	DP
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Dec. 01	MT
Investors Await Fed Chief's Interest Rates Signal as Exchange-Traded Funds, Equity Futures Slide Pre-Bell Friday	Dec. 01	MT
Wall St set for lower open in run-up to Powell's remarks	Dec. 01	RE
Sector Update: Health Care	Dec. 01	MT
Will Powell deliver an early Christmas present?	Dec. 01